FDA Inspection
FORDOZ PHARMA CORPORATIONFORDOZ PHARMA CORPORATION – FDA Inspection, Mar 17, 2023
Record Details
This FDA Inspection record concerns FORDOZ PHARMA CORPORATION, with an inspection on March 17, 2023, issued by the New Jersey District Office.
- Company
- FORDOZ PHARMA CORPORATION
- Inspection Date
- March 17, 2023
View Company Profile
ID · 00df13bf-d33e-4cb4-9e1d-9e893134df59
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1201660
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.142Written warehousing procedures established/followed
- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of FORDOZ PHARMA CORPORATION
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 12, 2025 | OAI | New Jersey District Office | Drug Quality Assurance |
Other documents for FORDOZ PHARMA CORPORATION
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.